MTOR and cancer: Metformin, another strong mTOR inhibitor and a widely used oral antidiabetic drug, has lately been receiving considerable attention for its cancer-preventive and cancer-therapeutic effects [149–151] and is on its way to being repurposed for preventive and therapeutic use in cancer patients - an example of “drug repositioning” [152].